A phase II study of NK012, a polymeric micelle formulation of SN-38, in unresectable, metastatic or recurrent colorectal cancer patients
出版年份 2018 全文链接
标题
A phase II study of NK012, a polymeric micelle formulation of SN-38, in unresectable, metastatic or recurrent colorectal cancer patients
作者
关键词
-
出版物
CANCER CHEMOTHERAPY AND PHARMACOLOGY
Volume 82, Issue 6, Pages 1021-1029
出版商
Springer Nature America, Inc
发表日期
2018-10-04
DOI
10.1007/s00280-018-3693-6
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A phase I dose escalation study of NK012, an SN-38 incorporating macromolecular polymeric micelle
- (2016) Howard A. Burris et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Irinotecan, a key chemotherapeutic drug for metastatic colorectal cancer
- (2015) Ken-ichi Fujita WORLD JOURNAL OF GASTROENTEROLOGY
- The antitumor activity of NK012, an SN-38-incorporating micelle, in combination with bevacizumab against lung cancer xenografts
- (2010) Hirotsugu Kenmotsu et al. CANCER
- Antitumor Effect of NK012, a 7-Ethyl-10-Hydroxycamptothecin-Incorporating Polymeric Micelle, on U87MG Orthotopic Glioblastoma in Mice Compared with Irinotecan Hydrochloride in Combination with Bevacizumab
- (2010) J.-i. Kuroda et al. CLINICAL CANCER RESEARCH
- Phase I Study of NK012, a Novel SN-38-Incorporating Micellar Nanoparticle, in Adult Patients with Solid Tumors
- (2010) T. Hamaguchi et al. CLINICAL CANCER RESEARCH
- Synergistic antitumor activity of the SN-38-incorporating polymeric micelles NK012 with S-1 in a mouse model of non-small cell lung cancer
- (2010) Tatsuya Nagano et al. INTERNATIONAL JOURNAL OF CANCER
- Antitumor Activity of NK012 Combined with Cisplatin against Small Cell Lung Cancer and Intestinal Mucosal Changes in Tumor-Bearing Mouse after Treatment
- (2009) T. Nagano et al. CLINICAL CANCER RESEARCH
- UGT1A1*6 polymorphism is most predictive of severe neutropenia induced by irinotecan in Japanese cancer patients
- (2009) Masahide Onoue et al. International Journal of Clinical Oncology
- Novel SN-38-Incorporated Polymeric Micelle, NK012, Strongly Suppresses Renal Cancer Progression
- (2008) M. Sumitomo et al. CANCER RESEARCH
- Antitumor Effect of SN-38-Releasing Polymeric Micelles, NK012, on Spontaneous Peritoneal Metastases from Orthotopic Gastric Cancer in Mice Compared with Irinotecan
- (2008) T. Eguchi Nakajima et al. CANCER RESEARCH
- Enhanced distribution of NK012, a polymeric micelle-encapsulated SN-38, and sustained release of SN-38 within tumors can beat a hypovascular tumor
- (2008) Yohei Saito et al. CANCER SCIENCE
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
- Synergistic antitumor activity of the novel SN-38-incorporating polymeric micelles, NK012, combined with 5-fluorouracil in a mouse model of colorectal cancer, as compared with that of irinotecan plus 5-fluorouracil
- (2008) Takako Eguchi Nakajima et al. INTERNATIONAL JOURNAL OF CANCER
- Potent antitumor effect of SN-38-incorporating polymeric micelle, NK012, against malignant glioma
- (2008) Jun-ichiro Kuroda et al. INTERNATIONAL JOURNAL OF CANCER
- EPIC: Phase III Trial of Cetuximab Plus Irinotecan After Fluoropyrimidine and Oxaliplatin Failure in Patients With Metastatic Colorectal Cancer
- (2008) Alberto F. Sobrero et al. JOURNAL OF CLINICAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started